Grants and Contributions:
Title:
Development of Novel Oral Appliance for Assisting Senior Population to Overcome a Sleep Related Breathing Disorder
Agreement Number:
1001285
Agreement Value:
$75,000.00
Agreement Date:
Jan 1, 2023 - Mar 15, 2024
Description:
The company aims to develop next two versions of improved Anti-snoring Oral Appliance prototypes to progress closer to commercial product for demonstrating to a larger sample of prospective prescriber or recommender stake holders (e.g. dentists, sleep physicians), to acquire potential sales and commercial feedback. The feedback and design and developmental improvements will be iterative, building upon current version of prototype already manufactured and demonstrated to limited stake holders.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Ottawa, Ontario, CA K1H 7Y7
Reference Number:
172-2022-2023-Q4-1001285
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
798357000
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 60 days.
Amendment Date
Feb 1, 2024
Recipient's Operating Name:
Sleep Labs Canada
Recipient's Legal Name:
Smile SleepLabs Inc.
Federal Riding Name:
Ottawa South
Federal Riding Number:
35077
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
339110
Amendments: